Relation between Serum Uric Acid Levels and Metabolic Syndrome Markers among Koreans by Gender
![]() |
Park, Hyunjin
(ICAN Nutrition Education and Research)
Ryu, Hyesook (Dept. of Food and Nutrition, Sangji University) Jho, Kwanghyun (Dept. of Business Administration, Sahmyook University) Ko, Jaeyoung (National Health Insurance Corporation Ilsan Haspital) Yun, Mieun (Dept. of Food and Nutrition, Sahmyook University) |
1 | Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, Streit J, Joseph-Ridge N. 2005. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 353:2450-2461 DOI |
2 | Billiet L, Doaty S, Katz JD, Velasquez MT. 2014. Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 16:852954 |
3 | Carbone F, Montecucco F, Mach F, Pontremoli R, Viazzi F. 2013. The liver and the kidney: Two critical organs influencing the atherothrombotic risk in metabolic syndrome. Thromb Haemost 110:940-958 DOI |
4 | Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT. 2005. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 183:147-155 DOI |
5 | Ding X, Zeng C, Wei J, Li H, Yang T, Zhang Y, Xiong YL, Gao SG, Li YS, Lei GH. 2016. The associations of serum uric acid level and hyperuricemia with knee osteoarthritis. Rheumatol Int 36:567-573 DOI |
6 | Feig DI, Kang DH, Johnson RJ. 2008. Uric acid and cardiovascular risk. N Engl J Med 359:1811-1821 DOI |
7 | Gagliardi AC, Miname MH, Santos RD. 2009. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis 202:11-17 DOI |
8 | Hyun DW, Kim KH, Yoon HJ, Kwon TG, Kim KY, Bae JH. 2007. Gender differences in the role of serum uric acid for predicting cardiovascular events in patients with coronary artery disease. Korean Circulation J 37:196-201 DOI |
9 | Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Fernando C. 2005. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement: Executive summary. Crit Pathw Cardiol 4:198-203 DOI |
10 | Hediger MA, Johnson RJ, Miyazaki H, Endou H. 2005. Molecular physiology of urate transport. Physiology (Bethesda) 20:125-133 DOI |
11 | Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, Tuttle KR, Rodriguez-Iturbe B, Herrera-Acosta J, Mazzali M. 2003. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41:1183-1190 DOI |
12 | Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. 2010. Hyperuricemia and coronary heart disease: A systematic review and meta-analysis. Arthritis Care Res (Hoboken) 62:170-180 |
13 | Kaur J. 2014. A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014:e943162 |
14 | Kawabe M, Sato A, Hoshi T, Sakai S, Hiraya D, Watabe H, Kakefuda Y, Ishibashi M, Abe D, Takeyasu N, Aonuma K. 2016. Gender differences in the association between serum uric acid and prognosis in patients with acute coronary syndrome. J Cardiol 67:170-176 DOI |
15 | Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. 2009. Hyperuricemia and risk of stroke: A systematic review and meta-analysis. Arthritis Rheum 61:885-892 DOI |
16 | Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, Yazici M, Keles I. 2006. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19:1055-1062 DOI |
17 | Lee YH, Yoon SJ, Kim HS, Oh SW, Ryu HS, Choo JA, Kim SN, Kim YA, Park MS, Park YS, Kim SY, Kwon AR. 2013. Design and preliminary results of a metropolitan lifestyle intervention program for people with metabolic syndrome in South Korea. Diabetes Res Clin Pract 101:293-302 DOI |
18 | Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, Zhang C. 2013. High serum uric acid and increased risk of type 2 diabetes: A systemic review and meta-analysis of prospective cohort studies. PLoS One 8:e56864 DOI |
19 | Nashar K, Fried LF. 2012. Hyperuricemia and the progression of chronic kidney disease: Is uric acid a marker or an independent risk factor? Adv Chronic Kidney Dis 19:386-91 DOI |
20 | Puig JG, Martinez MA. 2008. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 20:187-191 DOI |
21 | Rathmann W, Funkhouser E, Dyer AR, Roseman JM. 1998. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA study. Ann Epidemiol 8:250-261 |
22 | Richette P, Bardin T. 2010. Gout. Lancet 375:318-328 DOI |
23 | Tuttle KR, Short RA, Johnson RJ. 2001. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol 87:1411-1414 DOI |
24 | Viazzi F, Leoncini G, Vercelli M, Deferrari G, Pontremoli R. 2011. Serum uric acid levels predict new-onset type 2 diabetes in hospitalized patients with primary hypertension: The MAGIC study. Diabetes Care 34:126-128 DOI |
25 | Zhou Y, Wei F, Fan Y. 2016. High serum uric acid and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. Clin Biochem 49:636-642 DOI |
26 | Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG. 2005. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69:928-933 DOI |
![]() |